Institutional investors purchased a net $3.7 thousand shares of ATRI during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 49.88% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 25.4 Thousand shares of Atrion Corp